Knowledge Center

Patent / Jan 01, 2012

Medicament inhaler

Authors:
  • Peter Villax
Source:
HR 9500042

Also in the Knowledge Center

Related Content

Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform

Press Release / Feb 22, 2022
Article
View

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Health, Safety, Environment and Energy (HSEEn)

Zero accidents is our main goal

Page
Read more